First European application filed for product using intradermal microinjection system BD Soluvia
Novel influenza vaccine delivered using BD's innovative technology
18-Feb-2008 -
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, has submitted the first application in Europe to deliver a vaccine using BD Soluvia, a microinjection system developed by BD (Becton, Dickinson and Company). The submission for the first influenza vaccine using BD Soluvia has been ...
BD
clinical trials
immune cells
+4